Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Ryland · SciRah

Researcher profile · Semantic Scholar

K. Ryland

Share profile

K. Ryland — researcher profile on SciRah

h-index: 6
Works: 38
Citations: 178

Most-cited papers

Role for Myosin-V Motor Proteins in the Selective Delivery of Kv Channel Isoforms to the Membrane Surface of Cardiac Myocytes
Sarah M. Schumacher-Bass, Eileen D. Vesely, Lian Zhang, K. Ryland +6 more
2014Circulation Research40 citations Open access
Semantic Scholar
Polycomb-Dependent Repression of the Potassium Channel-Encoding Gene KCNA5 Promotes Cancer Cell Survival Under Conditions of Stress
K. Ryland, Laurie K. Svoboda, Eileen D. Vesely, Jeremy C. McIntyre +3 more
2014Oncogene25 citations Open access
Semantic Scholar
Promoter Methylation Analysis Reveals that KCNA5 Ion Channel Silencing Supports Ewing Sarcoma Cell Proliferation
K. Ryland, Allegra G. Hawkins, D. Weisenberger, V. Punj +4 more
2015Molecular Cancer Research23 citations Open access
Semantic Scholar
Diffuse Large B-Cell Lymphoma (DLBCL): A Structured Literature Review of the Epidemiology, Treatment Guidelines, and Real-World Treatment Patterns
M. Garg, J. Takyar, Arju Dhawan, Gurkiran Saggu +4 more
2022Blood20 citations Open access
Semantic Scholar
Ibrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia
Scott F. Huntington, E. de Nigris, J. Puckett, Sachin Kamal-Bahl +6 more
2023Leukemia and Lymphoma11 citations Open access
Semantic Scholar
Real-world treatment patterns, survival, health resource use and costs among Medicare beneficiaries with diffuse large B-cell lymphoma.
M. Garg, J. Puckett, Sachin Kamal-Bahl, M. Raut +3 more
2023Future Oncology7 citations Open access
Semantic Scholar
Zilovertamab Vedotin in Combination with Nemtabrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma: Cohort C of the Open-Label, Phase 2 Waveline-006 Study
E. Paszkiewicz-Kozik, Claudia Moreira, Mehmet Turgut, Marcelo Garrido +7 more
2024Blood6 citations
Semantic Scholar
Zilovertamab Vedotin Monotherapy for Patients with Relapsed or Refractory Mantle Cell Lymphoma: Cohort a of the Multicenter, Open-Label, Phase 2 Waveline-006 Study
I. Glimelius, W. Kim, E. Paszkiewicz-Kozik, Daniel Ernst +7 more
2024Blood6 citations
Semantic Scholar
Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting.
M. Garg, J. Puckett, Sachin Kamal-Bahl, M. Raut +3 more
2024Clinical Lymphoma, Myeloma & Leukemia5 citations Open access
Semantic Scholar
Real‐world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia
Scott F. Huntington, E. de Nigris, J. Puckett, Sachin Kamal-Bahl +6 more
2024Cancer Medicine5 citations Open access
Semantic Scholar
Real-World Treatment Patterns and Outcomes after Ibrutinib Discontinuation Among Elderly Medicare Beneficiaries with Chronic Lymphocytic Leukemia: An Observational Study
S. Huntington, E. de Nigris, J. Puckett, S. Kamal-Bahl +5 more
2022Blood5 citations Open access
Semantic Scholar
Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma After Frontline Transplant: A Multicenter, Randomized, Phase 3 Study (AURIGA)
Thomas S. Lin, S. Hampras, Ryan Krey, H. Pei +8 more
2019Clinical Lymphoma, Myeloma & Leukemia5 citations
Semantic Scholar
Assessing unmet need among elderly Medicare Beneficiaries with Mantle cell lymphoma: an analysis of treatment patterns, survival, healthcare resource utilization, and costs
P. Squires, J. Puckett, K. Ryland, S. Kamal-Bahl +3 more
2023Leukemia and Lymphoma4 citations Open access
Semantic Scholar
Keynote-B68: Updated Efficacy and Safety of Pembrolizumab Every Six Weeks in Relapsed/Refractory Classical Hodgkin Lymphoma or Primary Mediastinal B-Cell Lymphoma
A. McDonald, E. Verburgh, M. Gotti, Antonio Pinto +16 more
2023Blood3 citations Open access
Semantic Scholar
Economic Burden and Treatment Patterns Among Patients with Mantle Cell Lymphoma in the US: A Retrospective Claims Analysis
M. Garg, A. Satija, Yan Song, E. Sarpong +7 more
2022Blood2 citations Open access
Semantic Scholar
Real-World Treatment Patterns, Healthcare Resource Use, and Costs Among Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of US Claims Data
M. Garg, A. Satija, Yan Song, E. Sarpong +7 more
2022Blood2 citations Open access
Semantic Scholar
Economic burden and treatment patterns among patients with mantle cell lymphoma in the United States: a retrospective study of administrative claims data
Mahek Garg, Ambika Satija, Yan Song, E. Sarpong +4 more
2025Current Medical Research and Opinion1 citations
Semantic Scholar
Real-world treatment patterns, healthcare resource use, and costs among patients with diffuse large B-cell lymphoma: a retrospective analysis of US claims data
Mahek Garg, Ambika Satija, Yan Song, E. Sarpong +6 more
2025Leukemia and Lymphoma1 citations
Semantic Scholar
Real-world treatment patterns and clinical outcomes of patients with treatment-naïve and relapsed/refractory diffuse large B-cell lymphoma in the United States.
J. Lue, P. Bobbili, Mahek Garg, Christopher W. Yee +5 more
2025Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis1 citations
Semantic Scholar
Efficacy and safety of pembrolizumab every six weeks in relapsed/refractory classical Hodgkin lymphoma or primary mediastinal B-cell lymphoma: The phase 2 KEYNOTE-B68 trial.
A. Mcdonald, E. Verburgh, M. Gotti, A. Pinto +15 more
2023Journal of Clinical Oncology1 citations
Semantic Scholar
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
A. McDonald, E. Verburgh, M. Gotti, A. Pinto +16 more
2023Hematological Oncology1 citations Open access
Semantic Scholar
Real-World Treatment Patterns, Overall Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients with Mantle Cell Lymphoma (MCL) after Failure of Covalent Btki Treatment
P. Squires, J. Puckett, K. Ryland, Sachin Kamal-Bahl +3 more
2023Blood1 citations Open access
Semantic Scholar
Real-World Treatment Patterns, Healthcare Resource Utilization, Costs, and Survival Among Medicare Beneficiaries with Diffuse Large B-Cell Lymphoma (DLBCL)
M. Garg, S. Huntington, J. Puckett, S. Kamal-Bahl +3 more
2022Blood1 citations Open access
Semantic Scholar
Treatment Utilization Patterns, Health Resource Use, Costs, and Survival in Mantle Cell Lymphoma: A Real-World Analysis of a National Sample of Medicare Beneficiaries
P. Squires, S. Huntington, J. Puckett, K. Ryland +3 more
2022Blood1 citations Open access
Semantic Scholar
Role for Myosin-V Motor Proteins in the Selective Delivery of Kv Channel Isoforms to the Membrane Surface of Cardiac Myocytes
Ann Arbor, Sb, San Francisco, J. Martens +9 more
1 citations
Semantic Scholar
Treatment patterns in relapsed/refractory marginal zone lymphoma: real-world evidence from seven countries
H. Patel, L. Huynh, Patrick Squires, Jennifer Prescott +8 more
2026Future Oncology0 citations Open access
Semantic Scholar
Phase 2 study of MK-3475A in relapsed or refractory classic Hodgkin lymphoma or primary mediastinal large B-cell lymphoma.
A. Berkovits, Jessica Flynn, K. Ryland, R. Yusuf +1 more
2025Journal of Clinical Oncology0 citations Open access
Semantic Scholar
UPDATED RESULTS FROM KEYNOTE‐B68: PEMBROLIZUMAB EVERY 6 WEEKS IN PARTICIPANTS WITH RELAPSED OR REFRACTORY CLASSIC HODGKIN LYMPHOMA OR PRIMARY MEDIASTINAL B‐CELL LYMPHOMA
A. McDonald, E. Verburgh, M. Gotti, A. Pinto +16 more
2025Hematological Oncology0 citations
Semantic Scholar
FINAL SAFETY ANALYSIS IN PARTICIPANTS WITH HEMATOLOGIC MALIGNANCIES WHO RECEIVED ALLOGENEIC STEM CELL TRANSPLANT AFTER PEMBROLIZUMAB THERAPY
J. Kuruvilla, P. Armand, A. Herrera, V. Ribrag +6 more
2025Hematological Oncology0 citations
Semantic Scholar
Efficacy and Safety of Pembrolizumab Every Six Weeks in Relapsed/Refractory Classical Hodgkin Lymphoma or Primary Mediastinal B-Cell Lymphoma: Keynote-B68 Update
A. McDonald, E. Verburgh, M. Gotti, Antonio Pinto +16 more
2024Blood0 citations
Semantic Scholar
Real-World Treatment Patterns, Survival, and Economic Burden Among Elderly MCL Patients Previously Treated With cBTKis.
P. Squires, J. Puckett, K. Ryland, Sachin Kamal-Bahl +3 more
2024Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED/REFRACTORY SETTING
M. Garg, J. Puckett, S. Kamal-Bahl, M. Raut +4 more
2023HemaSphere0 citations Open access
Semantic Scholar
Real-World Analysis of Adverse Event Rates after Initiation of Ibrutinib Among Medicare Beneficiaries with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia By Ibrutinib Discontinuation Status
E. de Nigris, S. Huntington, J. Puckett, S. Kamal-Bahl +5 more
2022Blood0 citations Open access
Semantic Scholar
Assessing the Epidemiology, Treatment Patterns, and Economic Impact of Marginal Zone Lymphoma: A Review of the Literature
P. Squires, Priyanka Saini, P. Pandey, R. Pandey +4 more
2022Blood0 citations
Semantic Scholar
A Structured Literature Review Investigating the Current Treatment Landscape in Patients with Richter's Transformation (2011-2021)
J. Prescott, P. Pandey, Adam Hall, J. Nathani +4 more
2022Blood0 citations Open access
Semantic Scholar
Abstract 3288: The KCNA5 promoter is hypermethylated in Ewing sarcoma and silencing contributes to cell proliferation
K. Ryland, Allegra G. Hawkins, D. Weisenberger, S. Borinstein +3 more
20150 citations
Semantic Scholar
The Epigenetic Regulation of KCNA5 in Pediatric Solid Tumors and its Role in Cancer Biology.
K. Ryland
20150 citations
Semantic Scholar
Abstract 3968: Polycomb-mediated suppression of the voltage-gated potassium channel KCNA5 promotes Ewing sarcoma cell survival
K. Ryland, Laurie K. Svoboda, J. Martens, E. Lawlor
20140 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Puckett×12
Invite
J. Puckett — researcher profile on SciRah
J. Doshi×11
Invite
J. Doshi — researcher profile on SciRah
E. Sarpong×8
Invite
E. Sarpong — researcher profile on SciRah
M. Raut×8
Invite
M. Raut — researcher profile on SciRah

×7

Invite

M. Garg — researcher profile on SciRah

Invite

M. Raut — researcher profile on SciRah

Invite

J. Martens — researcher profile on SciRah

Scott F. Huntington×6

Invite

Scott F. Huntington — researcher profile on SciRah

Sachin Kamal-Bahl×6

Invite

Sachin Kamal-Bahl — researcher profile on SciRah

S. Huntington×6

Invite

S. Huntington — researcher profile on SciRah

S. Kamal-Bahl×6

Invite

S. Kamal-Bahl — researcher profile on SciRah

Invite

E. Verburgh — researcher profile on SciRah